Viking Therapeutics Inc (NASDAQ:VKTX) currently has a daily average trading volume of 3.27M but it saw 4742005 shares traded in last market. With a market cap of 5.60B USD, the company’s current market price of $50.77 came rising about 7.13 while comparing to the previous closing price of $47.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $99.41 and as low as $8.28.
Taking a look at 20-day trading activity of Viking Therapeutics Inc (VKTX) gives us an average price of $54.10, while its current price level is -48.93% below from 52-week high level whereas it is 513.16% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $63.93 while that of 200 days or SMA-200 reads an average of $39.00. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.14% during that period while stretching the period over a month that increases to 7.16%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.16 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which initiated the stock as “Overweight” in its note to investors issued on June 27, 2024, recommending a price target of $105 for it. Raymond James upgraded its recommendation for the stock as a “Strong Buy” from “Outperform” on May 16, 2024 while assigning a price target range of $115-$116. Oppenheimer issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $116 and $138.
Over the week, VKTX’s stock price is moving 0.67% up while it is -22.32% when we observe its performance for the past one month. Year-to-date it is 172.81% up and over the past year, the stock is showing an upside performance of 242.23%.
Currently, Viking Therapeutics Inc’s total number of outstanding shares is 110.27M. Company’s return on investment (ROI) stands at -10.03% and return on equity (ROE) at -17.55%. Stock’s beta reads 1.00. Stock has a price to book (P/B) ratio of 5.99. Its return on asset (ROA) is -16.76% on average.
